Company intelligence / Profile preview

Predawn Discovery Advisors

San Diego, California, United States

Ownership: Private
Employees: ~1
Development stage: Other

Overview

Predawn Discovery Advisors is a strategic consultancy firm providing expert guidance in early-stage drug discovery and development. The firm specializes in medicinal chemistry, lead optimization, and translational science to help biotechnology companies and investors navigate the complexities of the "predawn" phase of drug development. Their services include technical due diligence, portfolio strategy, and hands-on project management for small molecule programs. Led by industry veteran Dr. Mark G. Peterson, the firm bridges the gap between initial hit identification and the selection of robust clinical candidates.

Modalities: Small molecule
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Predawn Discovery Advisors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Predawn Discovery Advisors.

Explore the full profile